Cargando…
Ph(+)急性淋巴细胞白血病ABL激酶区突变患者的临床、分子遗传学特征和治疗选择
OBJECTIVE: To clarify the clinical, cytogenetical and molecular characteristics and prognosis of Ph(+) ALL patients with ABL kinase domain mutations (ABL-KDMs), and to evaluate the therapeutic value of allogeneic hematopoietic stem cell transplantation (allo-HSCT) combined with tyrosine kinase inhib...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348204/ https://www.ncbi.nlm.nih.gov/pubmed/27014978 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.02.004 |